purchase customization

1 Study Coverage
1.1 Preventable Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Preventable Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Market by Application
1.3.1 Global Preventable Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Preventable Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Preventable Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Preventable Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Preventable Vaccines Sales by Region
2.4.1 Global Preventable Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Preventable Vaccines by Region (2023-2028)
2.5 Global Preventable Vaccines Revenue by Region
2.5.1 Global Preventable Vaccines Revenue by Region (2017-2022)
2.5.2 Global Preventable Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Preventable Vaccines Sales by Manufacturers
3.1.1 Global Top Preventable Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Preventable Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Preventable Vaccines in 2021
3.2 Global Preventable Vaccines Revenue by Manufacturers
3.2.1 Global Preventable Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Preventable Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Preventable Vaccines Revenue in 2021
3.3 Global Preventable Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Preventable Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Preventable Vaccines Sales by Type
4.1.1 Global Preventable Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Preventable Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Preventable Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Preventable Vaccines Revenue by Type
4.2.1 Global Preventable Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Preventable Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Preventable Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Preventable Vaccines Price by Type
4.3.1 Global Preventable Vaccines Price by Type (2017-2022)
4.3.2 Global Preventable Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Preventable Vaccines Sales by Application
5.1.1 Global Preventable Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Preventable Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Preventable Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Preventable Vaccines Revenue by Application
5.2.1 Global Preventable Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Preventable Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Preventable Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Preventable Vaccines Price by Application
5.3.1 Global Preventable Vaccines Price by Application (2017-2022)
5.3.2 Global Preventable Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Preventable Vaccines Market Size by Type
6.1.1 North America Preventable Vaccines Sales by Type (2017-2028)
6.1.2 North America Preventable Vaccines Revenue by Type (2017-2028)
6.2 North America Preventable Vaccines Market Size by Application
6.2.1 North America Preventable Vaccines Sales by Application (2017-2028)
6.2.2 North America Preventable Vaccines Revenue by Application (2017-2028)
6.3 North America Preventable Vaccines Market Size by Country
6.3.1 North America Preventable Vaccines Sales by Country (2017-2028)
6.3.2 North America Preventable Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Preventable Vaccines Market Size by Type
7.1.1 Europe Preventable Vaccines Sales by Type (2017-2028)
7.1.2 Europe Preventable Vaccines Revenue by Type (2017-2028)
7.2 Europe Preventable Vaccines Market Size by Application
7.2.1 Europe Preventable Vaccines Sales by Application (2017-2028)
7.2.2 Europe Preventable Vaccines Revenue by Application (2017-2028)
7.3 Europe Preventable Vaccines Market Size by Country
7.3.1 Europe Preventable Vaccines Sales by Country (2017-2028)
7.3.2 Europe Preventable Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Preventable Vaccines Market Size by Type
8.1.1 Asia Pacific Preventable Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Preventable Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Preventable Vaccines Market Size by Application
8.2.1 Asia Pacific Preventable Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Preventable Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Preventable Vaccines Market Size by Region
8.3.1 Asia Pacific Preventable Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Preventable Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Preventable Vaccines Market Size by Type
9.1.1 Latin America Preventable Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Preventable Vaccines Revenue by Type (2017-2028)
9.2 Latin America Preventable Vaccines Market Size by Application
9.2.1 Latin America Preventable Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Preventable Vaccines Revenue by Application (2017-2028)
9.3 Latin America Preventable Vaccines Market Size by Country
9.3.1 Latin America Preventable Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Preventable Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Preventable Vaccines Market Size by Type
10.1.1 Middle East and Africa Preventable Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Preventable Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Preventable Vaccines Market Size by Application
10.2.1 Middle East and Africa Preventable Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Preventable Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Preventable Vaccines Market Size by Country
10.3.1 Middle East and Africa Preventable Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Preventable Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Takeda Pharmaceutical
11.6.1 Takeda Pharmaceutical Corporation Information
11.6.2 Takeda Pharmaceutical Overview
11.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Takeda Pharmaceutical Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Takeda Pharmaceutical Recent Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Overview
11.7.3 Abbott Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Roche Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Roche Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AstraZeneca Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Corporation Information
11.10.2 Mitsubishi Tanabe Pharma Overview
11.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mitsubishi Tanabe Pharma Recent Developments
11.11 Lupin
11.11.1 Lupin Corporation Information
11.11.2 Lupin Overview
11.11.3 Lupin Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lupin Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lupin Recent Developments
11.12 Serum Institute of India
11.12.1 Serum Institute of India Corporation Information
11.12.2 Serum Institute of India Overview
11.12.3 Serum Institute of India Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Serum Institute of India Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Serum Institute of India Recent Developments
11.13 LG Life Sciences
11.13.1 LG Life Sciences Corporation Information
11.13.2 LG Life Sciences Overview
11.13.3 LG Life Sciences Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 LG Life Sciences Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 LG Life Sciences Recent Developments
11.14 S K Chemicals
11.14.1 S K Chemicals Corporation Information
11.14.2 S K Chemicals Overview
11.14.3 S K Chemicals Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 S K Chemicals Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 S K Chemicals Recent Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Overview
11.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shenzhen Kangtai Biological Products Recent Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Overview
11.16.3 Sinovac Biotech Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sinovac Biotech Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sinovac Biotech Recent Developments
11.17 Janssen Pharmaceuticals
11.17.1 Janssen Pharmaceuticals Corporation Information
11.17.2 Janssen Pharmaceuticals Overview
11.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Janssen Pharmaceuticals Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Janssen Pharmaceuticals Recent Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Overview
11.18.3 Crucell Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Crucell Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Crucell Recent Developments
11.19 Bavarian Nordic
11.19.1 Bavarian Nordic Corporation Information
11.19.2 Bavarian Nordic Overview
11.19.3 Bavarian Nordic Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Bavarian Nordic Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Bavarian Nordic Recent Developments
11.20 Baxter
11.20.1 Baxter Corporation Information
11.20.2 Baxter Overview
11.20.3 Baxter Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Baxter Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Baxter Recent Developments
11.21 Bharat Biotech
11.21.1 Bharat Biotech Corporation Information
11.21.2 Bharat Biotech Overview
11.21.3 Bharat Biotech Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Bharat Biotech Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Bharat Biotech Recent Developments
11.22 Dynavax
11.22.1 Dynavax Corporation Information
11.22.2 Dynavax Overview
11.22.3 Dynavax Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Dynavax Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Dynavax Recent Developments
11.23 Bausch Health
11.23.1 Bausch Health Corporation Information
11.23.2 Bausch Health Overview
11.23.3 Bausch Health Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Bausch Health Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Bausch Health Recent Developments
11.24 Protein Sciences
11.24.1 Protein Sciences Corporation Information
11.24.2 Protein Sciences Overview
11.24.3 Protein Sciences Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Protein Sciences Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Protein Sciences Recent Developments
11.25 Panacea Biotec
11.25.1 Panacea Biotec Corporation Information
11.25.2 Panacea Biotec Overview
11.25.3 Panacea Biotec Preventable Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Panacea Biotec Preventable Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Panacea Biotec Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Preventable Vaccines Industry Chain Analysis
12.2 Preventable Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Preventable Vaccines Production Mode & Process
12.4 Preventable Vaccines Sales and Marketing
12.4.1 Preventable Vaccines Sales Channels
12.4.2 Preventable Vaccines Distributors
12.5 Preventable Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Preventable Vaccines Industry Trends
13.2 Preventable Vaccines Market Drivers
13.3 Preventable Vaccines Market Challenges
13.4 Preventable Vaccines Market Restraints
14 Key Findings in The Global Preventable Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer